CIK 0001576280
- Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 454139254
- Phone
- +1 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- 4 Open-market sale Chief Technology Officer sold 7,738 shares at $178.00 ($1,377,364)
- 4 Open-market sale Director sold 6,674 shares at an average $175.74 ($1,172,886)
- 4 Planned sale Director sold 826 shares at $175.00 ($144,550)
- 4 Planned sale Director sold 116 shares at $175.00 ($20,300)
- 4 Option exercise Director acquired 1,651 shares (option exercise)
- 4 Open-market sale Chief Information Officer sold 4,000 shares at $158.05 ($632,193)
- 4 Gift Co-Chief Executive Officer gave 30,000 shares (gift)
- 4 Open-market sale Co-Chief Executive Officer sold 37,500 shares at an average $169.16 ($6,343,384)
- 4 Option exercise Director acquired 264 shares (option exercise)
- 4 Option exercise Director acquired 232 shares (option exercise)
- 4 Planned sale Director sold 116 shares at $156.45 ($18,148)
- 4 Open-market sale Chief People Officer sold 46,300 shares at an average $165.12 ($7,645,218)
- 4 Gift Co-Chief Executive Officer gave 35,000 shares (gift)
- 4 Gift Co-Chief Executive Officer gave 75,000 shares (gift)
- 4 Gift Chief Legal Officer gave 800 shares (gift)
- 4 Open-market sale Chief Commercial Officer sold 63,605 shares at an average $169.58 ($10,786,111)
- 4 Open-market sale Director sold 1,700 shares at an average $164.24 ($279,202)
- 4 Open-market sale Director sold 14,180 shares at an average $158.92 ($2,253,451)
- 4 Option exercise Director acquired 264 shares (option exercise)
- 4 Option exercise Director acquired 232 shares (option exercise)
Page 2 of 44 · 876 filings